NCT02606903View on ClinicalTrials.gov

Pharmacokinetics and Safety of BI 695501 Administered Via Prefilled Syringe or Autoinjector

PHASE1CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

October 28, 2015

Primary Completion Date

September 7, 2016

Study Completion Date

October 4, 2016

Conditions
Healthy
Interventions
DRUG

BI 695501 prefilled syringe

DRUG

BI 695501 autoinjector

Trial Locations (1)

2060

SGS Belgium NV Research Unit Stuivenberg, Antwerp

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY